Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Efficacy and Safety of FMT in Ulcerative Colitis
NCT07154784Phase 3Enrolling by invitation
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2023
- Primary completion
- Jul 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of Fecal Microbiota Transplantation Capsule in ulcerative colitis (UC), sponsored by Seoul National University Hospital. Started Jul 2023; status: enrolling by invitation.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07154784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07154784.